icadmed.com - ICAD Operating profit EBITDA

Brandmark of icadmed.com (ICAD)

Cloud-based delivery of diagnostic data minimizes costs and accelerates diagnosis. The EBITDA level confirms the efficiency of this model, where the mark serves as a key metric. iCAD, Inc. (ICAD) utilizes proprietary AI software for mammography to protect its market niche, while management's experience in transforming the software portfolio drives growth in the number of subscriptions.

ICAD - iCAD Operating profit EBITDA over the range 07/04/2022 - 11/10/2026
Signature product of iCAD Corp

iCAD, Inc. (ICAD) optimizes oncology diagnostics by integrating artificial intelligence algorithms into partners' radiological equipment to enhance analysis accuracy. By analyzing actual operating profit, an investor can track daily cash flow from core operations before interest and taxes, enabling the timely identification of asset overvaluation risks should business operational efficiency deteriorate during market downturns.

Who iCAD, Inc. competes with

ONC - Operating profit before deduction of amortization|HALO: Operating profit before deduction of amortization|RVMD - Operating profit EBITDA|Ascentage Pharma (AAPG) - Profit before payment of interest, taxes and amortization|CG Oncology Inc - Income before deduction of interest, taxes and amortization|URGN (UroGen) - Operating profit EBITDA|Profit before interest, taxes and amortization Bicara Corp BCAX|Operating profit EBITDA PSNL|Operating income before deduction of amortization erasca.com|Operating profit EBITDA DCTH (Delcath Systems)|YMAB - Operating profit before deduction of amortization|Aura Bio - Operating profit EBITDA|CADL - Operating profit EBITDA|ARAY: Operating profit EBITDA|Operating profit before amortization SLS|Operating profit before deduction of amortization ACTU|CTOR: Income before deduction of interest, taxes and amortization|Operating profit EBITDA HURA|Operating income before deduction of amortization Protara Tx|Profit before payment of interest, taxes and amortization Fate Therapeutics, Inc. FATE|WHWK: Operating profit before amortization|TScan - Operating profit EBITDA|Champions Oncology (CSBR) - Operating profit before deduction of amortization|XBIT (xbiotech.com) - Operating profit before deduction of amortization|CVM - Operating income before deduction of amortization|OSTX (OS Therapies Incorporated) - Operating profit EBITDA|radiopharmtheranostics.com (RADX) - Operating income before deduction of amortization|Operating profit EBITDA ARTV|Operating profit before deduction of amortization adlainortye.com ANL|Operating profit EBITDA VERU (Veru Pharma)|Operating profit EBITDA Tempest Therapeutics Corp TPST|Xilio - Operating profit EBITDA|RENB (Renovaro Inc.) - Operating profit before amortization|MURA: Operating profit EBITDA|Operating profit before deduction of amortization Kairos Pharma|OKUR (OnKure Therapeutics, Inc.) - Operating profit EBITDA|Operating profit EBITDA CytoMed|Profit before payment of interest, taxes and amortization Curis, Inc. (CRIS)|apollomicsinc.com - Operating profit before amortization|Operating profit EBITDA THAR (Tharimmune)|ADVB - Operating profit before deduction of amortization|Genprex, Inc - Operating profit EBITDA|Profit before interest, taxes and amortization Calidi Biotherapeutics|Sunshine Biopharma, Inc. (SBFM) - Profit before payment of interest, taxes and amortization|Xenetic Biosciences, Inc. - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization SLRX|PPBT: Income before deduction of interest, taxes and amortization|Operating profit EBITDA AONC|Operating profit before deduction of amortization BeiGene Ltd BGNE|Checkpoint Therapeutics - Operating profit before deduction of amortization|Operating profit EBITDA elevationoncology.com ELEV|IKNA - Profit before payment of interest, taxes and amortization|Income before deduction of interest, taxes and amortization NTBL (Notable Labs Ltd)|VIRX: Operating profit EBITDA|Profit before interest, taxes and amortization MorphoSys Corporation (MOR)|NAYA (NAYA Biosciences) - Operating profit EBITDA|ascentage.com (AAPGV) - Operating income before deduction of amortization